Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MICRA-HYBRID Trial: A Randomized Controlled Trial of 'Multivessel Minimally Invasive Coronary Bypass Grafting as HYBRID Revascularization Versus Conventional Off-Pump Coronary Artery Bypass Grafting'

NCT07314138 is registered in ClinicalTrials.gov with Catharina Ziekenhuis Eindhoven as lead sponsor.

NCT NCT07314138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07314138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MICRA-HYBRID Trial: A Randomized Controlled Trial of 'Multivessel Minimally Invasive Coronary Bypass Grafting as HYBRID Revascularization Versus Conventional Off-Pump Coronary Artery Bypass Grafting'
Lead sponsor
Catharina Ziekenhuis Eindhoven
Phase
Not applicable
Overall status
Recruiting
Start date
August 25, 2026
Completion date
May 1, 2034
Enrollment
250 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bypass, cardiopulmonary, coronary artery disease (cad), minimally invasive coronary revascularization surgery, off-pump coronary artery bypass